相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Super enhancers as master gene regulators in the pathogenesis of hematologic malignancies
Sonia Debek et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2022)
STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming
Zhaowei Chu et al.
NATURE COMMUNICATIONS (2022)
ALKBH5/MAP3K8 axis regulates PD-L1+macrophage infiltration and promotes hepatocellular carcinoma progression
Yu You et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)
H3K27ac HiChIP in prostate cell lines identifies risk genes for prostate cancer susceptibility
Claudia Giambartolomei et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2021)
Epigenetically regulated gene expression profiles reveal four molecular subtypes with prognostic and therapeutic implications in colorectal cancer
Xiaokang Wang et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer
William M. Grady et al.
GASTROENTEROLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Super-enhancers: a new frontier for epigenetic modifiers in cancer chemoresistance
Guo-Hua Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
MAP3K8 Is a Prognostic Biomarker and Correlated With Immune Response in Glioma
Jing Ren et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Epigenetic mechanisms in breast cancer therapy and resistance
Liliana Garcia-Martinez et al.
NATURE COMMUNICATIONS (2021)
Landscape of EBV-positive gastric cancer
Motonobu Saito et al.
GASTRIC CANCER (2021)
ZNF507 affects TGF-β signaling via TGFBR1 and MAP3K8 activation in the progression of prostate cancer to an aggressive state
Wookbong Kwon et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Effect of MAP3K8 on Prognosis and Tumor-Related Inflammation in Renal Clear Cell Carcinoma
Jiatao Hao et al.
FRONTIERS IN GENETICS (2021)
Super-Enhancer Induced IL-20RA Promotes Proliferation/Metastasis and Immune Evasion in Colorectal Cancer
Dingye Yu et al.
FRONTIERS IN ONCOLOGY (2021)
Endothelial Tpl2 regulates vascular barrier function via JNK-mediated degradation of claudin-5 promoting neuroinflammation or tumor metastasis
Aikaterini Nanou et al.
CELL REPORTS (2021)
PLAGL2 promotes the proliferation and migration of gastric cancer cells via USP37-mediated deubiquitination of Snail1
Liang Wu et al.
THERANOSTICS (2021)
Burden of Gastric Cancer
Aaron P. Thrift et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
The emerging role of epigenetic therapeutics in immuno-oncology
Michael J. Topper et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
A super-enhancer controls TGF- β signaling in pancreatic cancer through downregulation of TGFBR2
Xiaolin Zhu et al.
CELLULAR SIGNALLING (2020)
Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity
Shannon Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Penicilazaphilone C, a New Azaphilone, Induces Apoptosis in Gastric Cancer by Blocking the Notch Signaling Pathway
Ming Wang et al.
FRONTIERS IN ONCOLOGY (2020)
Overexpression of B7-H3 in α-SMA-Positive Fibroblasts Is Associated With Cancer Progression and Survival in Gastric Adenocarcinomas
Shenghua Zhan et al.
FRONTIERS IN ONCOLOGY (2020)
Targeting the MAPK Pathway in KRAS-Driven Tumors
Matthias Drosten et al.
CANCER CELL (2020)
SPON2 Is Upregulated through Notch Signaling Pathway and Promotes Tumor Progression in Gastric Cancer
Hyeon-Gu Kang et al.
CANCERS (2020)
Bromodomain and Extraterminal (BET) protein inhibition suppresses tumor progression and inhibits HGF-MET signaling through targeting cancer-associated fibroblasts in colorectal cancer
Dongpeng Wen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Association between Epstein-Barr virus infection and gastric cancer: a systematic review and meta-analysis
Ahmad Tavakoli et al.
BMC CANCER (2020)
Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies
Julita Machlowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma
Rong Deng et al.
MOLECULAR CANCER (2020)
Cross-species chromatin interactions drive transcriptional rewiring in Epstein-Barr virus-positive gastric adenocarcinoma
Atsushi Okabe et al.
NATURE GENETICS (2020)
Epigenetic Therapies for Cancer
Susan E. Bates
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Epithelial-Mesenchymal Transition in Cancer: A Historical Overview
Domenico Ribatti et al.
TRANSLATIONAL ONCOLOGY (2020)
The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy
Jimin Yuan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
The Role of EBV-Induced Hypermethylation in Gastric Cancer Tumorigenesis
Lyla J. Stanland et al.
VIRUSES-BASEL (2020)
Targeting MAD2 modulates stemness and in human Gastric Cancer cell lines
Natalia Pajuelo-Lozano et al.
THERANOSTICS (2020)
Super-enhancer-driven AJUBA is activated by TCF4 and involved in epithelial-mesenchymal transition in the progression of Hepatocellular Carcinoma
Chi Zhang et al.
THERANOSTICS (2020)
Tumor progression locus 2 (TPL2) in tumor-promoting Inflammation, Tumorigenesis and Tumor Immunity
Lucy Wanjiru Njunge et al.
THERANOSTICS (2020)
Interchromosomal interactions: A genomic love story of kissing chromosomes
Philipp G. Maass et al.
JOURNAL OF CELL BIOLOGY (2019)
Advancement in TPL2-regulated innate immune response
Ming-Hao Yan et al.
IMMUNOBIOLOGY (2019)
Super-enhancers in cancer
Palaniraja Thandapani
PHARMACOLOGY & THERAPEUTICS (2019)
Targeting Alterations in the RAF-MEK Pathway
Rona Yaeger et al.
CANCER DISCOVERY (2019)
PD-L1 Expression in Human Breast Cancer Stem Cells Is Epigenetically Regulated through Posttranslational Histone Modifications
Pramod Darvin et al.
JOURNAL OF ONCOLOGY (2019)
Promoter methylation induced epigenetic silencing of DAZAP2, a downstream effector of p38/MAPK pathway, in multiple myeloma cells
Jiang Li et al.
CELLULAR SIGNALLING (2019)
Epigenetic regulation of lncRNA KCNKI5-ASI in gastric cancer
Haiyan Zhang et al.
CANCER MANAGEMENT AND RESEARCH (2019)
A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer
Cornelia Braicu et al.
CANCERS (2019)
Computational modeling reveals MAP3K8 as mediator of resistance to vemurafenib in thyroid cancer stem cells
Fiorenza Giani et al.
BIOINFORMATICS (2019)
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
Claudia Allemani et al.
LANCET (2018)
Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK-ERK and NF-κB pathways in a model of chronic myeloid leukemia
Anna Chorzalska et al.
MOLECULAR ONCOLOGY (2018)
Epigenetic regulation of long non-coding RNAs in gastric cancer
Zhixia Zhou et al.
Oncotarget (2018)
Up-regulation of HOXB cluster genes are epigenetically regulated in tamoxifen-resistant MCF7 breast cancer cells
Seoyeon Yang et al.
BMB REPORTS (2018)
Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells
Takatsugu Ishimoto et al.
GASTROENTEROLOGY (2017)
Novel insights into chromosomal conformations in cancer
Ruobing Jia et al.
MOLECULAR CANCER (2017)
TGFB-induced transcription in cancer
Gaia Cantelli et al.
SEMINARS IN CANCER BIOLOGY (2017)
CtBP2 overexpression promotes tumor cell proliferation and invasion in gastric cancer and is associated with poor prognosis
Faxiang Dai et al.
ONCOTARGET (2017)
Overexpression of α-sma-positive fibroblasts (CAFs) in Nasopharyngeal Carcinoma Predicts Poor Prognosis
Jiewei Chen et al.
JOURNAL OF CANCER (2017)
Notch as a Driver of Gastric Epithelial Cell Proliferation
Elise S. Demitrack et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2017)
RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action
Julien Masliah-Planchon et al.
ONCOTARGET (2016)
Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity
Wen Fong Ooi et al.
NATURE COMMUNICATIONS (2016)
Pathological complete response after cisplatin neoadjuvant therapy is associated with the downregulation of DNA repair genes in BRCA1- associated triple-negative breast cancers
Pawel Domagala et al.
ONCOTARGET (2016)
BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
Hengrui Zhu et al.
CELL REPORTS (2016)
Epigenetically regulated miR-145 suppresses colon cancer invasion and metastasis by targeting LASP1
Wei Wang et al.
ONCOTARGET (2016)
MAP3K8/TPL-2/COT is a potential predictive marker for MEK inhibitor treatment in high-grade serous ovarian carcinomas
Tina Gruosso et al.
NATURE COMMUNICATIONS (2015)
Tpl2 induces castration resistant prostate cancer progression and metastasis
Hye Won Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
α-Smooth muscle actin-positive myofibroblasts, in association with epithelial-mesenchymal transition and lymphogenesis, is a critical prognostic parameter in patients with oral tongue squamous cell carcinoma
Lei Ding et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies
Thomas De Raedt et al.
NATURE (2014)
MAP3K8 kinase regulates myeloma growth by cell-autonomous and non-autonomous mechanisms involving myeloma-associated monocytes/macrophages
Ellen Hebron et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Alpha-Smooth Muscle Actin (ACTA2) Is Required for Metastatic Potential of Human Lung Adenocarcinoma
Hye Won Lee et al.
CLINICAL CANCER RESEARCH (2013)
Overexpression of CK20, MAP3K8 and EIF5A correlates with poor prognosis in early-onset colorectal cancer patients
Berrin Tunca et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Cancer Epigenetics: From Mechanism to Therapy
Mark A. Dawson et al.
CELL (2012)
Topological domains in mammalian genomes identified by analysis of chromatin interactions
Jesse R. Dixon et al.
NATURE (2012)
TPL2/COT/MAP3K8 (TPL2) Activation Promotes Androgen Depletion-Independent (ADI) Prostate Cancer Growth
Joseph H. Jeong et al.
PLOS ONE (2011)
Prediction of epigenetically regulated genes in breast cancer cell lines
Leandro A. Loss et al.
BMC BIOINFORMATICS (2010)
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Cory M. Johannessen et al.
NATURE (2010)
Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion
Mirang Kim et al.
MOLECULAR CANCER RESEARCH (2008)
Epigenetic inactivation of protein kinase D1 in gastric cancer and its role in gastric cancer cell migration and invasion
Mirang Kim et al.
CARCINOGENESIS (2008)
CLCA2 tumour suppressor gene in 1p31 is epigenetically regulated in breast cancer
XR Li et al.
ONCOGENE (2004)
Mutational activation of the MAP3K8 protooncogene in lung cancer
AM Clark et al.
GENES CHROMOSOMES & CANCER (2004)
The oncogenic protein kinase Tpl-2/Cot contributes to Epstein-Barr virus-encoded latent infection membrane protein 1-induced NF-κB signaling downstream of TRAF2
AG Eliopoulos et al.
JOURNAL OF VIROLOGY (2002)
Looping, linking, and chromatin activity:: New insights into β-globin locus regulation
JD Engel et al.
CELL (2000)
分享论文
